[May 24, 2013] Shares of WuXi PharmaTech Cayman Rank the Lowest in Terms of Forward P/E Ratio in the Life Sciences Tools & Services Industry (WX, CBM, PKI, A, TMO) Tweet May 24, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Life Sciences Tools & Services industry with the lowest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among companies in the same industry. Generally, the lower the forward P/E, the more undervalued a company is believed to be.WuXi PharmaTech Cayman ranks lowest with a a forward P/E ratio of 12.33. Following is Cambrex with a a forward P/E ratio of 13.19. PerkinElmer ranks third lowest with a a forward P/E ratio of 13.67. Agilent Technologies follows with a a forward P/E ratio of 14.28, and Thermo Fisher Scientific rounds out the bottom five with a a forward P/E ratio of 14.33. SmarTrend recommended that subscribers consider buying shares of WuXi PharmaTech Cayman on August 9th, 2012 as our technology indicated a new Uptrend was in progress when shares hit $14.53. Since that recommendation, shares of WuXi PharmaTech Cayman have risen 43.8%. We continue to monitor WuXi PharmaTech Cayman for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]